Cite
Huo W, Zhao G, Yin J, et al. Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells. J Cancer. 2017;8(1):57-64doi: 10.7150/jca.16723.
Huo, W., Zhao, G., Yin, J., Ouyang, X., Wang, Y., Yang, C., Wang, B., Dong, P., Wang, Z., Watari, H., Chaum, E., Pfeffer, L. M., & Yue, J. (2017). Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells. Journal of Cancer, 8(1), 57-64. https://doi.org/10.7150/jca.16723
Huo, Wenying, et al. "Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells." Journal of Cancer vol. 8,1 (2017): 57-64. doi: https://doi.org/10.7150/jca.16723
Huo W, Zhao G, Yin J, Ouyang X, Wang Y, Yang C, Wang B, Dong P, Wang Z, Watari H, Chaum E, Pfeffer LM, Yue J. Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells. J Cancer. 2017 Jan 01;8(1):57-64. doi: 10.7150/jca.16723. eCollection 2017. PMID: 28123598; PMCID: PMC5264040.
Copy
Download .nbib